Abstract
Beta blockers may benefit patients with dilated cardiomyopathy but low output failure can be a problem. Thus a beta 1-selective beta blocker with about 45% intrinsic sympathomimetic activity (ISA), such as xamoterol, was thought to have a desirable pharmacologic profile. Long-term studies of xamoterol in patients with idiopathic dilated cardiomyopathy have shown improved cardiac performance and exercise tolerance, while exercise heart rate, left ventricular ejection fraction, and pulmonary artery wedge pressure were decreased. This improvement in exercise capacity and overall quality of life in patients treated with xamoterol has been confirmed in further controlled trials of patients with mild-to-moderate heart failure (NYHA class I and II). However, in patients with moderate-to-severe heart failure (NYHA class III and IV), mortality was unfavorably influenced by xamoterol. The therapeutic role of xamoterol in patients with heart disease needs further refinement.
References
Jun 30, 1979·Lancet·K SwedbergI Wallentin
Oct 1, 1975·British Heart Journal·F WaagsteinI Wallentin
Apr 1, 1990·European Heart Journal·R M TimewellH F Marlow
Feb 1, 1985·The American Journal of Cardiology·J L AndersonM Bartholomew
Jul 1, 1985·British Heart Journal·A O Molajo, D H Bennett
Jan 1, 1986·European Journal of Clinical Pharmacology·L BarriosH de Geest
Jan 1, 1988·European Journal of Clinical Pharmacology·E V SorensenW Bastain
Sep 1, 1985·Circulation·R S EngelmeierR M Gunnar
Sep 1, 1966·The American Journal of Cardiology·S A Stephen
Oct 1, 1973·American Heart Journal·D J Greenblatt, J Koch-Weser
May 10, 1980·Lancet·R C Wetzel
Aug 1, 1980·British Heart Journal·K SwedbergI Wallentin
Aug 1, 1980·British Heart Journal·K SwedbergI Wallentin
Mar 1, 1981·American Heart Journal·M BrezisJ Hasin
Oct 1, 1984·British Heart Journal·A O MolajoD H Bennett
Aug 7, 1965·British Medical Journal·P M GILLAM, B N PRICHARD
Citations
Sep 5, 2001·International Journal of Cardiology·D J van Veldhuisen, P A Poole-Wilson
Oct 9, 2002·Congestive Heart Failure·Denise D Hermann
Jan 1, 1997·Journal of Clinical Pharmacology·T W Hash, L M Prisant
May 29, 2008·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Jeffrey K Aronson
Jul 10, 2002·Journal of the American College of Cardiology·Harold L Kennedy, Robert S Rosenson
Jun 28, 2011·International Journal of Cardiology·Ravi V DesaiAli Ahmed
Dec 1, 1993·Circulation·P W Armstrong, G W Moe
May 22, 2002·Circulation·Peter AndrekaNanette H Bishopric
Dec 26, 2001·Hypertension·R JoannidesC Thuillez
Sep 1, 1996·Journal of Gambling Studies·G C Anders
Dec 25, 2013·Molecular Pharmacology·Emma T van der WesthuizenMichel Bouvier
Apr 1, 1995·Cardiovascular Drugs and Therapy·V PanfilovG Olsson
Aug 16, 2005·International Journal of Cardiology·Sergio V Perrone, Edgardo J Kaplinsky